New hope for patients with sarcopenic obesity unable to join clinical trials
NCT ID NCT06784297
First seen Mar 10, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This program provides expanded access to an experimental treatment called IMM01-STEM for people with sarcopenic obesity—a condition where both muscle loss and excess body fat occur. It is designed for patients who cannot participate in other clinical trials due to eligibility, location, or other reasons. The goal is to offer potential benefit to those who have limited options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.